TSXV - Delayed Quote
CAD
Avricore Health Inc. (AVCR.V)
0.0500
0.0000
(0.00%)
At close: November 2 at 9:29:59 AM EST
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Rodger Seccombe
|
CEO, CTO & Director | 261.73k | 17k | 1981 |
|
Ms. Kiriaki Smith CPA, CFO, CGA
|
CFO & Corporate Secretary | 144.31k | -- | 1967 |
|
Mr. Will Seccombe
|
Communications Advisor | -- | -- | -- |
Avricore Health Inc.
- Sector:
- Healthcare
- Industry: Diagnostics & Research
Description
Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
Corporate Governance
Avricore Health Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
December 1, 2026 at 9:00 PM UTC
Avricore Health Inc. Earnings Date
Recent Events
November 21, 2016 at 12:00 AM UTC
Dividend Date
